about
(18)F-Fluorine-18-l-dihydroxyphenylalanine ((18)F-DOPA) positive isolated peritoneal carcinomatosis from a MENII-related medullary thyroid carcinoma. About an atypical metastatic site and utility of (18)F-FDOPA.Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial.Feasibility and performance of lymphoscintigraphy in sentinel lymph node biopsy for early cervical cancer: results of the prospective multicenter SENTICOL studyDevelopment of Photoonycholysis with Vandetanib Therapy.Nonsurgical giant cell tumour of the tendon sheath or of the diffuse type: are MRI or 18F-FDG PET/CT able to provide an accurate prediction of long-term outcome?Contribution of lymphoscintigraphy to intraoperative sentinel lymph node detection in early cervical cancer: Analysis of the prospective multicenter SENTICOL cohort.Local recurrence of pheochromocytoma in multiple endocrine neoplasia type 2A: a diagnostic and therapeutic challenge.[Postoperative external beam radiotherapy for medullary thyroid carcinoma with high risk of locoregional relapse].Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition.A clinical evaluation of the impact of the Bayesian penalized likelihood reconstruction algorithm on PET FDG metrics.Comparison of an alternative and existing binning methods to reduce the acquisition duration of 4D PET/CT.The sentinel node technique detects unexpected drainage pathways and allows nodal ultrastaging in early cervical cancer: insights from the multicenter prospective SENTICOL study.Clinical outcomes 1 year after empiric 131I therapy for hyperthyroid disorders: real life experience and predictive factors of functional response.Oncocytic Adenoma of Thyroid Incidentally Detected by 18F-Fluorocholine PET/CT.Activity and Safety of Sunitinib in Patients with Advanced Radioiodine Refractory Thyroid Carcinoma: A Retrospective Analysis of 57 Patients.Routine FDG PET-CT in patients with a high-risk localized melanoma has a high predictive positive value for nodal disease and high negative predictive value for the presence of distant metastases.Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study.Accuracy of 18-Fluoro-2-deoxy-d-glucose Positron Emission Tomography in the Pretherapeutic Detection of Occult Para-aortic Node Involvement in Patients with a Locally Advanced Cervical CarcinomaDefective efficacy of retinoic acid treatment in patients with metastatic thyroid carcinomaIodine-131 pharmacokinetics in patients on hemodialysis for end stage renal disease: clinical implications[Systematic neck dissection in squamous cell carcinoma of the oral cavity][Critical study of our initial experience of 993 sentinel node biopsies for breast surgery][An individualized prognosis for truncal melanoma? A series of 77 cases]Functional testicular evaluation using PET/CT with 18F-fluorodeoxyglucoseEvaluation of 2 diuretic 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography imaging protocols for intrapelvic cancerRadioactive iodine therapy, molecular imaging and serum biomarkers for differentiated thyroid cancer: 2017 guidelines of the French Societies of Nuclear Medicine, Endocrinology, Pathology, Biology, Endocrine Surgery and Head and Neck SurgeryRisk of Hematologic Malignancies After Radioactive Iodine Treatment of Thyroid Cancer: An Unjustified WarningOutcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial
P50
Q35155742-5A75397E-4C8D-4B28-902E-E562F027F355Q35736722-6F53EA59-C98F-4428-8E4F-C0BAD4B2E0BCQ36322842-DE66C2FF-B69E-4777-8A30-205B7C4A55FAQ37604797-A7796CE4-28ED-4F4C-944D-547E0CD260C2Q38264850-BFBC0C62-0A94-43DA-AE0F-91A5AE6ED3E2Q38366397-9AFA1ECE-70A1-45BC-905A-4CBF6C12CFA8Q38685712-2D5D78CF-55E6-4D07-832E-836FA05681F4Q40659377-A4C7E71E-07DB-4DDB-9321-687516066C02Q43669829-1665D903-6AC5-4916-9A04-EFCA36B6F794Q47643321-6C30AC3B-210A-443E-8007-B2E861F8F057Q48813476-2AE01654-B379-4593-B526-5FFCD9A1BBB6Q50242376-AF443083-6A21-493B-BBDC-141FF085910FQ50526591-1BC738E7-9E78-4248-9B79-8183ECD7297BQ53016141-D20AD9FC-F57F-434F-B999-4FA690DE3181Q53074666-E6DFF6B1-093D-449B-886E-08344FAFFBC7Q53195557-C2CF3CA3-8D30-4546-B4F6-9120FBCAD104Q53243638-D0D1CDF9-5548-4479-840D-48063CF90739Q55603215-9ABE31B9-1647-46D1-9ACE-8C3635BB16CDQ62977941-91BEF254-5AAA-448C-BDBF-BC6619E12471Q79248730-859001A6-4159-4EE4-8FAC-F099C357CD60Q79251449-1F11F683-018D-4B87-BBA8-E1168FCBBA9CQ80730120-667AB273-7230-4BB2-9332-3BC251F8B1D0Q81893048-B79B4086-E688-46C0-BD58-5D10EEBECC49Q84065852-5E8BB545-032C-4A50-BD84-85622C1C798DQ84935425-675B09C6-34B8-46E6-8AAE-683313C0A159Q87706010-A463B7E0-8681-4773-B6E6-B3D7F3D34AEDQ88231221-CBA78A8D-7ED1-443A-B2D5-19E78F7BAB57Q88556186-DFD8AE4C-E145-41EE-B61A-64AE578016C4Q88884736-FFBF0651-D3D1-4077-9B96-6190F308F10D
P50
description
researcher ORCID ID = 0000-0002-1851-8970
@en
wetenschapper
@nl
name
Slimane Zerdoud
@ast
Slimane Zerdoud
@en
Slimane Zerdoud
@es
Slimane Zerdoud
@nl
type
label
Slimane Zerdoud
@ast
Slimane Zerdoud
@en
Slimane Zerdoud
@es
Slimane Zerdoud
@nl
prefLabel
Slimane Zerdoud
@ast
Slimane Zerdoud
@en
Slimane Zerdoud
@es
Slimane Zerdoud
@nl
P106
P31
P496
0000-0002-1851-8970